Anti-obesity drugs acting on the gastro-intestinal tract

Prescribe only as part of an overall plan for managing obesity in adults who have:

  • BMI of 28.0 kg/m2 or more with associated risk factors, or
  • BMI of 30.0 kg/m2 or more.
  • Continue treatment for longer than 3 months only if the person has lost at least 5% of their initial body weight since starting drug treatment
  • Continue for longer than 12 months only after discussing potential benefits and limitations with the patient.
84 capsule
  • First Line Drugs
  • Second Line Drugs
  • Specialist Initiated Drugs with Shared Care Guidelines
  • Specialist Only Drugs
  • Mixed Status